About this journal

Aims and scope

No longer published by Taylor & Francis

Psychiatry and Clinical Psychopharmacology aims to reach a national and international audience and will accept submissions from authors worldwide. It gives high priority to original studies of interest to clinicians and scientists in applied and basic neurosciences and related disciplines. Psychiatry and Clinical Psychopharmacology publishes high quality research targeted to specialists, residents and scientists in psychiatry, psychology, neurology, pharmacology, molecular biology, genetics, physiology, neurochemistry, and related sciences. 


Topics of current interest to clinical, experimental and basic scientists are published in critical subjects, such as psychopharmacology, psychiatry and behavioral science. Psychiatry and Clinical Psychopharmacology effectively bridges the gap between basic science and clinical application. Access to the Journal is available to all interested persons with no subscription fees, furthering the aim of reaching all interested national and international associations and individuals.

Psychiatry and Clinical Psychopharmacology
was formerly titled Bulletin of Clinical Psychopharmacology from the first volume in 1990 until 2016.

 

The standard article publishing charge (APC) for this journal is £575 / US$750 / €665. Depending on your location these charges may be subject to local taxes. Once your paper has been assessed for suitability by the editor, it will then be single blind peer-reviewed by independent, anonymous, expert referees.

Sorry, there are currently no metrics available for this journal.

Abstracting and indexing

Psychiatry and Clinical Psychopharmacology is indexed in the following databases/resources:

British Library Direct, Cabell''s Directory, Chemical Abstracts(CAS), Citefactor, Current Awareness in Biological Sciences (CABS), DOAJ, EBSCOhost Current Abstracts, EBSCOhost TOC premier, Elsevier BIOBASE, EMBASE (Excerpta Medica), Google Scholar, HINARI, Index Copernicus, International Pharmaceutical Abstracts (IPA), PROQUEST DATABASE: ProQuest Psychology Journals, ProQuest Health & Medical Complete, PsychINFO/Psychological Abstracts, PsycSCAN: Psychopharmacology, SCI-E (Science Citation Index- Expanded), Scopus, DOAJ, Thomson Master Journal List, TUBITAK TIP DIZINI and Turkiye Citation Index.

Open access

Psychiatry and Clinical Psychopharmacology is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.

Why choose open access?

  1. Increase the discoverability and readership of your article
  2. Make an impact and reach new readers, not just those with easy access to a research library
  3. Freely share your work with anyone, anywhere
  4. Comply with funding mandates and meet the requirements of your institution, employer or funder
  5. Rigorous peer review for every open access article

Article Publishing Charges (APC)

To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.

Use our APC finder to calculate your article publishing charge